Sessile serrated adenomas

High-risk lesions?

Safia N. Salaria, Mirte M. Streppel, Linda A Lee, Christine A. Iacobuzio-Donahue, Elizabeth A Montgomery

Research output: Contribution to journalArticle

Abstract

Sessile serrated adenomas (SSAs) were unrecognized in pathology and gastroenterology practice until about 2005; we have diagnosed them since 2001, allowing up to 10 years of follow-up. We evaluated follow-up of patients with sessile serrated adenoma diagnosed between 2002 and 2004 in our teaching institution and compared it to follow-up of randomly selected tubular adenomas. Materials from patients diagnosed with sessile serrated adenoma from January 2002 to December 2004 were reviewed. A control group of patients with sporadic tubular adenomas was selected. Ninety-nine sessile serrated adenomas from 93 patients were diagnosed between January 2002 and December 2004. Forty three patients (46.2%) had follow-up colonoscopy. One or more lesions were found in 42 (97.6%) of 43 patients. Mucinous adenocarcinoma was diagnosed in 1 (2.3%) of 43 patients, and 1 (2.3%) of 43 patients had high-grade dysplasia in an sessile serrated adenoma. Sessile serrated adenomas were found in 22 (51.2%) of 43 patients, 16 (37.2%) of 43 patients had tubular adenomas, and hyperplastic polyps were diagnosed in 18 (41.9%) of 43. Ninety-two patients with tubular adenomas between January 2002 and December 2004 formed the control group. Sixty-six patients (71.7%) received follow-up colonoscopy. Most (53/66, 80.3%) patients had tubular adenomas on follow-up, 12 (18.2%) of 66 patients had hyperplastic polyps, and 2 (3.0%) of 66 patients had a sessile serrated adenoma. The follow-up of sessile serrated adenomas from the study period (2002 to 2004) was more rigorous than proposed for sporadic tubular adenomas (patients with sporadic tubular adenomas were also followed up more aggressively than suggested by guidelines). Those with follow-up were managed as per advanced adenomas; their clinical outcomes supported this. These results suggest that guidelines for following up patients with sessile serrated adenomas as per advanced adenomas are warranted.

Original languageEnglish (US)
Pages (from-to)1808-1814
Number of pages7
JournalHuman Pathology
Volume43
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Adenoma
Colonoscopy
Polyps
Guidelines
Mucinous Adenocarcinoma
Control Groups
Gastroenterology

Keywords

  • Colorectal carcinoma
  • Follow-up colonoscopy
  • Serrated neoplasia
  • Serrated polyp
  • Sessile serrated adenoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Sessile serrated adenomas : High-risk lesions? / Salaria, Safia N.; Streppel, Mirte M.; Lee, Linda A; Iacobuzio-Donahue, Christine A.; Montgomery, Elizabeth A.

In: Human Pathology, Vol. 43, No. 11, 11.2012, p. 1808-1814.

Research output: Contribution to journalArticle

Salaria, SN, Streppel, MM, Lee, LA, Iacobuzio-Donahue, CA & Montgomery, EA 2012, 'Sessile serrated adenomas: High-risk lesions?', Human Pathology, vol. 43, no. 11, pp. 1808-1814. https://doi.org/10.1016/j.humpath.2012.04.001
Salaria, Safia N. ; Streppel, Mirte M. ; Lee, Linda A ; Iacobuzio-Donahue, Christine A. ; Montgomery, Elizabeth A. / Sessile serrated adenomas : High-risk lesions?. In: Human Pathology. 2012 ; Vol. 43, No. 11. pp. 1808-1814.
@article{0724c6b59ed94d1b9281521f656ba705,
title = "Sessile serrated adenomas: High-risk lesions?",
abstract = "Sessile serrated adenomas (SSAs) were unrecognized in pathology and gastroenterology practice until about 2005; we have diagnosed them since 2001, allowing up to 10 years of follow-up. We evaluated follow-up of patients with sessile serrated adenoma diagnosed between 2002 and 2004 in our teaching institution and compared it to follow-up of randomly selected tubular adenomas. Materials from patients diagnosed with sessile serrated adenoma from January 2002 to December 2004 were reviewed. A control group of patients with sporadic tubular adenomas was selected. Ninety-nine sessile serrated adenomas from 93 patients were diagnosed between January 2002 and December 2004. Forty three patients (46.2{\%}) had follow-up colonoscopy. One or more lesions were found in 42 (97.6{\%}) of 43 patients. Mucinous adenocarcinoma was diagnosed in 1 (2.3{\%}) of 43 patients, and 1 (2.3{\%}) of 43 patients had high-grade dysplasia in an sessile serrated adenoma. Sessile serrated adenomas were found in 22 (51.2{\%}) of 43 patients, 16 (37.2{\%}) of 43 patients had tubular adenomas, and hyperplastic polyps were diagnosed in 18 (41.9{\%}) of 43. Ninety-two patients with tubular adenomas between January 2002 and December 2004 formed the control group. Sixty-six patients (71.7{\%}) received follow-up colonoscopy. Most (53/66, 80.3{\%}) patients had tubular adenomas on follow-up, 12 (18.2{\%}) of 66 patients had hyperplastic polyps, and 2 (3.0{\%}) of 66 patients had a sessile serrated adenoma. The follow-up of sessile serrated adenomas from the study period (2002 to 2004) was more rigorous than proposed for sporadic tubular adenomas (patients with sporadic tubular adenomas were also followed up more aggressively than suggested by guidelines). Those with follow-up were managed as per advanced adenomas; their clinical outcomes supported this. These results suggest that guidelines for following up patients with sessile serrated adenomas as per advanced adenomas are warranted.",
keywords = "Colorectal carcinoma, Follow-up colonoscopy, Serrated neoplasia, Serrated polyp, Sessile serrated adenoma",
author = "Salaria, {Safia N.} and Streppel, {Mirte M.} and Lee, {Linda A} and Iacobuzio-Donahue, {Christine A.} and Montgomery, {Elizabeth A}",
year = "2012",
month = "11",
doi = "10.1016/j.humpath.2012.04.001",
language = "English (US)",
volume = "43",
pages = "1808--1814",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Sessile serrated adenomas

T2 - High-risk lesions?

AU - Salaria, Safia N.

AU - Streppel, Mirte M.

AU - Lee, Linda A

AU - Iacobuzio-Donahue, Christine A.

AU - Montgomery, Elizabeth A

PY - 2012/11

Y1 - 2012/11

N2 - Sessile serrated adenomas (SSAs) were unrecognized in pathology and gastroenterology practice until about 2005; we have diagnosed them since 2001, allowing up to 10 years of follow-up. We evaluated follow-up of patients with sessile serrated adenoma diagnosed between 2002 and 2004 in our teaching institution and compared it to follow-up of randomly selected tubular adenomas. Materials from patients diagnosed with sessile serrated adenoma from January 2002 to December 2004 were reviewed. A control group of patients with sporadic tubular adenomas was selected. Ninety-nine sessile serrated adenomas from 93 patients were diagnosed between January 2002 and December 2004. Forty three patients (46.2%) had follow-up colonoscopy. One or more lesions were found in 42 (97.6%) of 43 patients. Mucinous adenocarcinoma was diagnosed in 1 (2.3%) of 43 patients, and 1 (2.3%) of 43 patients had high-grade dysplasia in an sessile serrated adenoma. Sessile serrated adenomas were found in 22 (51.2%) of 43 patients, 16 (37.2%) of 43 patients had tubular adenomas, and hyperplastic polyps were diagnosed in 18 (41.9%) of 43. Ninety-two patients with tubular adenomas between January 2002 and December 2004 formed the control group. Sixty-six patients (71.7%) received follow-up colonoscopy. Most (53/66, 80.3%) patients had tubular adenomas on follow-up, 12 (18.2%) of 66 patients had hyperplastic polyps, and 2 (3.0%) of 66 patients had a sessile serrated adenoma. The follow-up of sessile serrated adenomas from the study period (2002 to 2004) was more rigorous than proposed for sporadic tubular adenomas (patients with sporadic tubular adenomas were also followed up more aggressively than suggested by guidelines). Those with follow-up were managed as per advanced adenomas; their clinical outcomes supported this. These results suggest that guidelines for following up patients with sessile serrated adenomas as per advanced adenomas are warranted.

AB - Sessile serrated adenomas (SSAs) were unrecognized in pathology and gastroenterology practice until about 2005; we have diagnosed them since 2001, allowing up to 10 years of follow-up. We evaluated follow-up of patients with sessile serrated adenoma diagnosed between 2002 and 2004 in our teaching institution and compared it to follow-up of randomly selected tubular adenomas. Materials from patients diagnosed with sessile serrated adenoma from January 2002 to December 2004 were reviewed. A control group of patients with sporadic tubular adenomas was selected. Ninety-nine sessile serrated adenomas from 93 patients were diagnosed between January 2002 and December 2004. Forty three patients (46.2%) had follow-up colonoscopy. One or more lesions were found in 42 (97.6%) of 43 patients. Mucinous adenocarcinoma was diagnosed in 1 (2.3%) of 43 patients, and 1 (2.3%) of 43 patients had high-grade dysplasia in an sessile serrated adenoma. Sessile serrated adenomas were found in 22 (51.2%) of 43 patients, 16 (37.2%) of 43 patients had tubular adenomas, and hyperplastic polyps were diagnosed in 18 (41.9%) of 43. Ninety-two patients with tubular adenomas between January 2002 and December 2004 formed the control group. Sixty-six patients (71.7%) received follow-up colonoscopy. Most (53/66, 80.3%) patients had tubular adenomas on follow-up, 12 (18.2%) of 66 patients had hyperplastic polyps, and 2 (3.0%) of 66 patients had a sessile serrated adenoma. The follow-up of sessile serrated adenomas from the study period (2002 to 2004) was more rigorous than proposed for sporadic tubular adenomas (patients with sporadic tubular adenomas were also followed up more aggressively than suggested by guidelines). Those with follow-up were managed as per advanced adenomas; their clinical outcomes supported this. These results suggest that guidelines for following up patients with sessile serrated adenomas as per advanced adenomas are warranted.

KW - Colorectal carcinoma

KW - Follow-up colonoscopy

KW - Serrated neoplasia

KW - Serrated polyp

KW - Sessile serrated adenoma

UR - http://www.scopus.com/inward/record.url?scp=84867849222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867849222&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2012.04.001

DO - 10.1016/j.humpath.2012.04.001

M3 - Article

VL - 43

SP - 1808

EP - 1814

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -